Radiofrequency ablation of stage IA non–small cell lung cancer in patients ineligible for surgery: results of a prospective multicenter phase II trial

BACKGROUND: A prospective multicenter phase II trial to evaluate the survival outcomes of percutaneous radiofrequency ablation (RFA) for patients with stage IA non-small cell lung cancer (NSCLC), ineligible for surgery. METHODS: Patients with a biopsy-proven stage IA NSCLC, staging established by a...

Descripción completa

Detalles Bibliográficos
Autores principales: Palussière, J., Chomy, F., Savina, M., Deschamps, F., Gaubert, J. Y., Renault, A., Bonnefoy, O., Laurent, F., Meunier, C., Bellera, C., Mathoulin-Pelissier, S., de Baere, T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109264/
https://www.ncbi.nlm.nih.gov/pubmed/30143031
http://dx.doi.org/10.1186/s13019-018-0773-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6109264/
https://www.ncbi.nlm.nih.gov/pubmed/30143031
http://dx.doi.org/10.1186/s13019-018-0773-y

Ejemplares similares